Discover 4,504 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,504
FeaturedActive & Responsive
Healing Track Clinical Trial
for
Chronic Back Pain
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 21 - 70
Code: NCT06641102
Recruiting
Featured
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Neptune City NJ, Montreal, Syracuse NY, Ottawa, Toronto,
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT02468024
Phase3, Recruiting
Active & Responsive
Anterior Cervical Discectomy and Fusion (ACDF) - Behavioral Intervention
for
Dysphagia
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 21 - 70+
Code: NCT06520579
Recruiting
Active & Responsive
Radiofrequency Ablation for BIII Thyroid Nodules
for
Indeterminate Bethesda III Thyroid Nodules
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18+
Code: NCT05189808
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: London, Boston MA, Providence RI, Trois-Rivieres,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase2, Recruiting
Active & Responsive
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT06338995
Phase3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Rimouski, Boston MA, New Haven CT, Quebec,